No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference
Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell's Phase 3 Study in Metastatic Breast Cancer
BriaCell Therapeutics Corp: INTERIM MDA EN
BriaCell Therapeutics Corp: INTERIM FINANCIAL STATEMENTSREPORT EN
BriaCell Therapeutics Reports Continued Financial Challenges
10-Q: Q2 2025 Earnings Report